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I N T R O D U C T I O N
Proteins of the BCL-2 family such as BCL-xL and BAX play an important role in the regulation of cell death, but the mechanisms by which they accomplish this are as yet incompletely understood (Adams and Cory 2007) . After a death stimulus to a cell, BCL-2 family proteins contribute to, or inhibit the release of, pro-apoptotic factors such as cytochrome c from mitochondria perhaps by influencing ion channel activity (Antonsson et al. 1997; Bonanni et al. 2006; Dejean et al. 2005; Minn et al. 1997; Schendel et al. 1998) . Recent evidence indicates that BCL-2 family proteins also modulate the function of neurons that are not undergoing cell death (Fannjiang et al. 2003; Jonas et al. 2003) . In particular, within the presynaptic terminal of a neuronal synapse, mitochondria regulate synaptic activity during high-frequency firing by buffering rapid changes in calcium levels and by modulating levels of ATP during and after intense neurotransmission (Hollenbeck 2005; Jonas et al. 2003) . In the synapse, acute translocation of recombinant BCL-xL protein into mitochondria produces ion channel activity on mitochondrial outer membranes, potentiates neurotransmitter release, and enhances recovery of depleted vesicle pools after intense synaptic activity, possibly by increasing the availability of ATP within the synaptic compartment (Jonas et al. 2003) . BCL-xL may act locally to modulate synaptic transmission, without regulating apoptosis of the cell soma, because the synapse is isolated from the nucleus of the cell (Arnold et al. 1974; Mason et al. 2007 ).
In addition to their possible constitutive activities, a number of the BCL-2 family proteins such as Bax, BID, BCL-2, and BCL-xL (Cheng et al. 1997; Clem et al. 1998; Condorelli et al. 2001; Fujita et al. 1998; Li et al. 1998; Nakagawa and Yuan 2000; Wood and Newcomb 2000) undergo proteolytic cleavage after a cell death stimulus, enhancing the pro-death activities of these molecules. In the case of BCL-xL, endogenous cleavage by caspases or calpains produces a C-terminal fragment that has Bax-like pro-apoptotic activity. The resulting protein (⌬N BCL-xL) lacks the BH4 domain that is thought to confer protection against apoptosis but still contains the deathinducing BH3 domain (Clem et al. 1998; Jonas et al. 2004) . It is likely that conformational rearrangements coincident with removal of the N terminus contribute to the pro-apoptotic activity of the cleaved BCL-xL protein, perhaps especially in the brain, where BCL-xL is highly expressed (Krajewska et al. 2002) . ⌬N BCL-xL produces large conductance ion channel activity in the outer mitochondrial membrane and may induce cell death in part by contributing to the increase in conductance of this membrane and the release of cytochrome c from mitochondria after a cell death stimulus (Clem et al. 1998; Jonas et al. 2004) . In addition to these death-promoting activities, the pro-apoptotic form of BCL-xL, when injected into a presynaptic terminal, causes a decline in synaptic responses that mimics that recorded during acute hypoxic insults to the synapse (Jonas et al. 2003 (Jonas et al. , 2005b .
Cleavage of BCL-xL alters its function from anti-to proapoptotic. Both pro-and anti-apoptotic molecules may contribute not only to regulation of cell death, but to other nervous system activities such as synaptic plasticity (Fannjiang et al. 2003; Jonas 2006) . The prediction therefore is that acute or long-term inhibition of endogenous BCL-xL would not only alter the response of neurons to cell death stimuli but could impair synaptic function in the absence of a death stimulus. In this study, we disrupt the activities of BCL-xL with ABT-737, a mimetic of the BH3-only protein BAD that binds to BCL-xL with high affinity within a pocket of the three-dimensional structure that usually binds pro-apoptotic proteins containing a BH3 domain (Oltersdorf et al. 2005) . The structure of ABT-737, a thioethylamino-2-4-dimethylphenyl analog, was designed to bind to the three-dimensional structure of BCL-xL/ BCL-2. By confocal time-lapsed microscopy experiments, the binding of ABT-737 was found to displace a green fluorescent protein (GFP)-tagged BH3-only protein from BCL-xL at mitochondrial surfaces in intact tumor cells. In cancer cell lines, ABT-737 alone effectively induces cell death possibly via its ability, as a BAD mimetic, to displace from BCL-xL the prebound pro-apoptotic proteins Bax and Bak (Oltersdorf et al. 2005) . ABT-737, because of its BAD-like activity, is selective for binding to anti-apoptotic molecules BCL-xL, BCL-2 and BCL-w (van Delft et al. 2006 ), but it binds BCL-xL with highest affinity in vitro (Oltersdorf et al. 2005) . BCL-xL is the most highly expressed of these proteins in the adult brain (Krajewska et al. 2002) .
We tested the acute effects of ABT-737 at a neuronal presynaptic terminal. When injected into the presynaptic terminal just before synaptic transmission, ABT-737 inhibits the channel activity of mitochondrial membranes that is normally activated during short-term synaptic plasticity and slows the recovery of neurotransmission following repetitive synaptic activity. When injected before a hypoxic insult of the synapse, however, ABT-737 also prevents the appearance of the large conductance activity of mitochondrial membranes associated with declining synaptic function. Furthermore, ABT-737 attenuates synaptic dysfunction produced by hypoxia or by exogenous injection of ⌬N BCL-xL into the synaptic terminal. Taken together, the findings suggest that BCL-xL is necessary for the constitutive functioning of neuronal synapses, and further, raises the possibility that ⌬N BCL-xL contributes endogenously to the attenuation of synaptic function after ischemic injury.
M E T H O D S

Intracellular membrane patch-clamp recordings
Experiments were performed on small Loligo pealii at the Marine Biological Laboratory, Woods Hole, MA, as described previously (Jonas et al. 1997 (Jonas et al. , 1999 . In brief, isolated squid stellate ganglia were pinned to Sylgard in a Lucite chamber. The bathing solution (in mM: 466 NaCl, 54 MgCl 2 , 11 CaCl 2 , 10 KCl, 3 NaHCO 3 , 10 HEPES, pH 7.2) was cooled, oxygenated with 99.5% O 2 -0.5% CO 2 , and perfused over the ganglia. Intracellular membrane pipettes (20 -80 M⍀) were filled with intracellular solution containing (in mM) 570 KCl, 1.2 MgCl 2 , 10 HEPES, 0.07 EGTA, 0.046 CaCl 2 , and 2 ATP, pH 7.2. The mitochondrial patch electrode was contained in an outer, ensheathing electrode that was used to enter the terminal, after which the outer electrode was retracted, exposing the patch pipette tip (Jonas et al. 1997) . Gigaohm seals formed either spontaneously or in response to slight negative pressure. The polarities of potentials reported here refer to those of the patch pipette relative to that of the ground electrode, which was placed in the external medium. As indicated, the mitochondrial patch electrode contained control intracellular solution or ABT-737 (5 M for patch recordings dissolved in 0.05% DMSO in control intracellular solution). Solutions within the patch pipette were not changed during the recording. Data represent populations of patch recordings exposed to the two different solutions.
Injection of presynaptic terminal and measurement of postsynaptic responses
Intracellular microinjection pipettes were filled with intracellular squid solution alone or with the protein or drug of interest and inserted into the presynaptic terminal. ABT-737 was used at a concentration of 500 M in the pipette for injection into the presynaptic terminal during postsynaptic recordings. After injection, the final concentration of ABT-737 within the synapse was estimated to be ϳ5 M. All injection pipettes also contained FITC-dextran of 3,000 molecular weight (MW; Molecular Probes, 100 M), which was coinjected with proteins or drugs into the terminal to detect successful injection of peptide and or drug (Morgan et al. 2001) . Pulses of positive pressure (20 -40 psi, 100 ms), were given with a Picospritzer (General Valve, Parker Hannifin Corp.) to achieve injection of the pipette solution.
Synaptic transmission was evoked by stimulating an external suction electrode attached to the presynaptic nerve. The nerve was stimulated at 0.033 Hz, 20 V, and 0.01 mS to elicit single action potentials. The postsynaptic responses were recorded by an electrode containing 3 M KCl inserted into the postsynaptic nerve. Transmitter release was measured by recording the initial rate of rise of the postsynaptic response (Jonas et al. 2003; Swandulla et al. 1991 ). The initial rates of rise of the postsynaptic responses were calculated using pClamp 8.0 or 9.0 Clampfit software (Axon Instuments) by placing a cursor at the first onset of the synaptic response, determined by eye, and a second cursor at a time point 100 -300 s later, before any detectable regenerative response occurred (Morgan et al. 2001; Swandulla et al. 1991) . To mimic high-frequency events, tetanic stimulation (50 Hz, 2-5 s) was applied to the presynaptic nerve.
To produce hypoxic conditions, the perfusion of the stellate ganglion with oxygenated seawater was stopped. Previous studies have determined, using a Clark type oxygen electrode (Hansatech, Norfolk, UK), that levels of oxygen in the medium surrounding the ganglia fall by 48.1 Ϯ 1.1% in 20 min (Jonas et al. 2005b ) after cessation of flow.
R E S U L T S
We propose that BCL-xL may be one of a number of mitochondrial proteins that regulate acute and long-term synaptic changes (Fannjiang et al. 2003; Jonas et al. 2003 Jonas et al. , 2004 Jonas et al. , 2005a and therefore that an inhibitor of BCL-xL may affect synaptic function. We have shown previously that BCL-xL is present on mitochondria in the stellate ganglion of the squid and that channel activity of mitochondria can be increased either by application of recombinant BCL-xL protein directly to mitochondria or by electrical stimulation of the squid presynaptic nerve (Jonas et al. 1999 (Jonas et al. , 2003 .
We had previously observed that mitochondrial outer membrane channel activity increased during high-frequency firing of the presynaptic nerve. To test the possibility that channel activity of BCL-xL could be contributing to mitochondrial channel activity during synaptic events, we recorded channel activity of mitochondrial membranes during synaptic stimulation (tetanus), in the presence or absence of the BCL-xL inhibitor, ABT-737 (Oltersdorf et al. 2005) . Consistent with previous observations, the new study indicated that, without treatment, mitochondrial channel activity increased during and after the tetanus (Jonas et al. 1999) (Fig. 1A) . The peak amplitude of the stimulus-evoked mitochondrial activity ranged from 2 to 60 times that of control activity recorded just before stimulation (Fig. 1, A and C) . The onset of the change in activity was never observed to occur concomitantly with the first action potential but occurred with a delay, suggesting that a diffusible messenger such as calcium present within the presynaptic terminal could be responsible for causing the onset of the change in mitochondrial activity. In addition, mitochondrial activity outlasted the end of the stimulus. There was variability in the time of onset of the response and the duration of the response, perhaps reflecting the position of the mitochondria with respect to the active zone. To illustrate typical time courses, we selected recordings from mitochondria that had long-lasting responses (Fig. 1 , A and C; n ϭ 7) or recordings from mitochondria that responded more briefly (Fig. 1, B and D; n ϭ 4) . The time course of the activity of long-lasting responders peaked as late as 60 s after the onset of the stimulus, (20 Hz, 5 s; Fig. 1, A and C) . As previously reported, synaptic mitochondrial responses were usually reversible, and in the long-lasting group, activity returned to control levels within 100 s of the onset of the stimulus. In the more briefly responding group, responses were smaller, and activity, although it outlasted the stimulus, returned to baseline earlier (Fig. 1, B and D) .
In contrast to control synapses, 62.5% of which responded to stimulation, only one of eight synapses (12.5%) treated with 5 M ABT-737 in the bath and in the patch pipette responded to stimulation with increased mitochondrial membrane activity during or following the tetanus (P Ͻ 0.02, Fisher's exact test; Fig. 1, E and G) . The mean peak current of the response in ABT-737-treated synapses was also less than that of controls (P Ͻ 0.02, Mann-Whitney; Fig. 1F ), suggesting that BCL-xL protein, or another target of ABT-737 (BCL-2 or BCL-w), contributes significantly to the modulation of such activity.
Mitochondria are abundant in the synaptic terminals of neurons that are capable of firing at high frequencies (Rowland et al. 2000; Tolbert and Morest 1982) and are known to be involved in presynaptic responses to high-frequency stimulation including posttetanic potentiation (Friel and Tsien 1994; Jonas et al. 1999; Tang and Zucker 1997) and in recovery of neurotransmission after synaptic depression (Billups and Forsythe 2002; Jonas et a. 2003) . Injection of BCL-xL into the presynaptic terminal increases the rate of recovery of transmitter release after a period of rapid firing (Jonas et al. 2003) , suggesting that it enhances the performance of mitochondria in recovery. We therefore tested the effects of ABT-737 on the rate of recovery from tetanic stimulation.
In control untreated synapses, recovery of neurotransmitter release generally occurred in Ͻ2 min, such that, within 2 min of the end of a 5-s tetanus, the recorded postsynaptic potentials were indistinguishable from those before the tetanus (Fig. 2, A  and C) . Moreover, when a second tetanic stimulus was applied at a time 8 -30 min after the first, the rate of recovery was unchanged from that observed in the first tetanus ( Fig. 2A; FIG. 1. ABT-737 prevents the appearance of channels on mitochondrial outer membrane during synaptic stimulation. A: recording on an outer mitochondrial membrane within a squid presynaptic terminal before, during, and after a tetanus. Channel activity increases after the tetanus and remains elevated for many tens of seconds and then returns to baseline (Jonas et al. 1999) . B: an example of a recording in which small conductance activity appears briefly during and after stimulation. C: time course of change in normalized mean current integral for large responses. Mean current integral (amplitude times frequency of channel opening) was calculated for each 10-s period before and after a tetanus. Data were normalized to maximum value for each experiment. D: time course of change in normalized mean current integral of mitochondrial membranes during small responses. Normalized mean current integral during each 1-s period was plotted. E: application of 5 M ABT-737 to the mitochondrial patch before synaptic stimulation prevents the increase in channel activity during and after the tetanus. Recording is representative of 7 of the 8 recordings made with ABT-737 in the patch pipette. F: histogram comparing mean current integral in the10-s period with the maximum evoked channel activity after stimulation in control synapses vs. those exposed to ABT-737 in the patch pipette (*P Ͻ 0.03). G: percentage of recordings in which channel activity occurred during synaptic stimulation in controls and ABT-737 exposed mitochondrial patches (n ϭ 32 controls and n ϭ 8 ABT-737-treated synapses; P Ͻ 0.02, Fisher's exact test).
recovery at 1 min was 104 Ϯ 3% of that in first tetanus; n ϭ 6), and in those in which a third tetanus was recorded, recovery was 102.5% of that in the second tetanus (n ϭ 2). In contrast, when ABT-737 was injected into or over the presynaptic terminal just before tetanic stimulation of the synapse, it caused a marked decrease in the rate at which the synapse recovered from high-frequency firing (Fig. 2B ). In the same synapse before and after ABT-737 application (n ϭ 4), recovery remained incomplete for as long as 6 min after the end of the second tetanus (Fig. 2, B and C) . In three experiments, a third tetanic stimulus was applied 10 -17 min after the second stimulus. The effect of ABT in this third tetanus persisted (time to 50% recovery ϭ 3.5 Ϯ 1.7 min for 1st ABT-737 tetanus and 3.3 Ϯ 1.1 m for 2nd ABT-737 stimulus).
In addition to experiments in which we compared rates of recovery in the same synapses before and after application of ABT-737, we also compared the mean time courses of recovery in unpaired untreated synapses and ABT-737-treated synapses (Fig. 2D) . Again, the rate of recovery was significantly slower in ABT-737-treated preparations, such that recovery was lower compared with the controls at all time points Յ7 min following stimulation. Although the mean time courses of recovery appeared slightly slower in the unpaired group data, there was no statistically significant difference between control and ABT-737-treated synapses 8 min following tetanic stimulation (Fig. 2D) . The results suggest that BCL-xL or another target of ABT-737 is an endogenous modulator of neurotransmission in the squid presynaptic terminal.
In apoptosis or during insults to the nervous system, there occurs an increase in permeability of the outer mitochondrial membrane (Gross et al. 1999; Halestrap 2005; Jonas et al. 2004; Kroemer and Reed 2000; Nakagawa et al. 2005) . Even in the absence of cell death, it is possible that such increases in permeability influence synaptic transmission (Jonas et al. 2005a ). In the squid synapse, the effects of hypoxia have served as a model for the effects of a cell death stimulus on synaptic activity (Jonas et al. 2005b ). In particular, the presynaptic terminal is sensitive to hypoxia, which attenuates synaptic transmission over 10 -30 min (Jonas et al. 2005b ). Patchclamp recordings of mitochondrial membranes made during the early phases of decline in synaptic activity showed large conductance channels not found frequently in controls. This activity is correlated with the appearance of ⌬N-BCL-xL, which is known to induce cell death and cytochrome c release (Bonanni et al. 2006; Clem et al. 1998; Fujita et al. 1998; Jonas et al. 2004) .
To carry out a more specific test of the hypothesis that ⌬N BCL-xL could contribute to synaptic rundown, recordings were performed in the presence of ABT-737. Previous work has shown that hypoxia produces large conductance activity with unitary conductances of Ͼ750 pS on mitochondrial membranes (Jonas et al. 2005b) . In this study, these findings were again verified (Fig. 3, A and B) . Hypoxia produced intermediate (Ͼ180 and Ͻ760 pS) and large (Ն760 pS) conductance channel activity (n ϭ 8) that was not present in controls. In contrast, in the presence of ABT-737, no large conductance activity occurred after hypoxia ( Fig. 3 ; n ϭ 8), although a small, but not statistically significant increase in intermediate conductances (Ͼ180 and Ͻ760 pS) occurred compared with ABT-treated controls (Fig. 3B, right) . The results suggest that BCL-xL or a proteolytic cleavage product of BCL-xL may contribute to the large conductance activity present after an hypoxic insult.
Hypoxia normally causes significant impairment of synaptic transmission in squid (Jonas et al. 2005b) . During this synaptic depression, the depolarization of the postsynaptic cell may become insufficient to elicit a postsynaptic action potential, resulting in failure of transsynaptic signaling. The onset of synaptic depression is correlated with a decrease in slope of the initial 100 -300 s of the postsynaptic response (Morgan et al. 2001; Swandulla et al. 1991) . When the synapse was exposed to ABT-737 both in the bath and by injection into the presynaptic terminal, rundown of synaptic responses was significantly delayed (Fig. 4) , such that 20 min after arresting the flow of oxygenated sea water to the ganglion, a full response to release of transmitter followed by an action potential in the postsynaptic cell could still be observed only in the ABT-737-treated synapses (Fig. 4, A, B, and D) . Exposure to ABT-737 (shown in Fig. 4C ) occasionally even transiently enhanced synaptic transmission immediately after the onset of hypoxia, but was unable to enhance transmission when injected into the terminal after full synaptic rundown had already occurred (n ϭ 2).
The large conductance mitochondrial activity following hypoxia and the rundown of synaptic transmission have been correlated with specific proteolytic cleavage of BCL-xL (Jonas et al. 2004 (Jonas et al. , 2005b . We therefore recorded synaptic responses after injection of recombinant ⌬N-BCL-xL protein into the synapse and compared these responses to those of synapses treated with both ⌬N-BCL-xL protein and ABT-737 (Fig. 5) . ⌬N BCL-xL enhanced the rate of decline of synaptic responses in oxygenated sea water as previously described (Jonas et al. 2004) (Fig. 5, A and B) . In contrast, such rundown was significantly delayed by ABT-737 (Fig. 5, A and B) . In some cases, as described above for hypoxia, postsynaptic potentials were transiently enhanced in the presence of ATP-737 with ⌬N BCL-xL before eventual rundown (Fig. 5A ).
D I S C U S S I O N
Here we report that BCL-xL has seemingly opposite effects on synaptic transmission. Modulation of BCL-xL by the BAD mimetic ABT-737 prevents the onset of stimulation-induced mitochondrial channel activity and slows the rate of recovery of synaptic responses after intense synaptic activity. Thus BCL-xL function seems to be required for the normal change in conductance of the outer mitochondrial membrane during synaptic transmission and also for the normal rate of recovery of neurotransmission after synaptic depression. In contrast, during hypoxia, BCL-xL seems to enhance synaptic rundown. In such hypoxic synapses, treatment with ABT-737 slows the decline in synaptic function and attenuates the appearance of large conductance channels in mitochondrial outer membranes within the presynaptic terminal.
The finding that ABT-737 inhibits ion channel activity on mitochondrial membranes during a tetanus suggests that such activity is produced in part by BCL-xL. The importance of the BH3 domain of BCL-xL for its channel-forming activity has been described by us previously (Jonas et al. 2004) , and it is intriguing that a mimetic of the BH3-only protein BAD, when bound into the BH3-containing pocket of BCL-xL, inhibits channel activity. One might speculate that binding of another protein "ligand" in the BCL-xL pocket is required for channel activity and that ABT-737 inhibits this interaction. BCL-xL itself may form a channel in the outer membrane (Minn et al. 1997) or form a subunit of a multi-protein complex that conducts ions and metabolites through the outer membrane (Vander Heiden et al. 2001) .
Another finding of this study is that ABT-737 slows recovery of synaptic transmission after synaptic depression. Our previous work suggested that injection of recombinant BCL-xL protein into the synapse speeds recovery from synaptic depression by regulating the refilling of specific neurotransmittercontaining pools within the presynaptic terminal (Jonas et al. 2003) . In that study, we suggested that BCL-xL may enhance the availability of ATP within the presynaptic terminal possibly to stimulate an ATP dependent step in the refilling of specific pools (Jonas et al. 2003) . ATP is known to be required for a myriad of cellular processes, and certain steps in synaptic vesicle mobilization, release, and recycling may be compromised by the lack of locally generated ATP. For example, enzyme-dependent steps in synaptic transmission include refilling of single vesicles with neurotransmitter (Takamori et al. 2000) , membrane fission during endocytosis (Heidelberger 2001), coated pit formation (Faundez and Kelly 2000; Smythe et al. 1989) , and fast compensatory membrane retrieval (Heidelberger 2001) . Previous work using Drosophila melanogaster mutants has suggested that mitochondria are necessary for normal vesicle recycling. A mutation of Drp1, which encodes a mitochondrial fission protein, was associated with the absence of mitochondria at presynaptic sites, abnormal synaptic transmission, and decreased activity of an ATP-sensitive myosin light chain kinase that is necessary for vesicle mobilization (Guo et al. 2005; Verstreken et al. 2005) . In the absence of mitochondria, synaptic transmission and vesicle recycling can take place, but more slowly, especially during times of high demand (high-frequency events) when the vesicle pools become rapidly depleted. It is therefore likely that mitochondrial ion channel activity plays a specific role in regulating the restoration of certain pools of vesicles but that other pools may not be so acutely dependent on mitochondrial activity. Undoubtedly, additional as yet unknown ATP-dependent molecular processes of vesicle recycling may be regulated by the presence of BCL-xL at synaptic sites.
One surprising finding of the study is that, under certain circumstances, the inhibitor of BCL-xL, rather than attenuating synaptic responses, actually enhances transmission. This is apparent after a traditional death stimulus, that of hypoxia, which has been shown previously to produce synaptic decline (Jonas et al. 2005b ). Many BCL-2 family proteins undergo proteolytic cleavage after a cell death stimulus, which serves to activate pro-apoptotic features of the molecules (Cheng et al. 1997; Clem et al. 1998; Fujita et al. 1998; Nakagawa and Yuan 2000) . From previous work, we know that cell death stimuli promote the N-terminal proteolytic cleavage of BCL-xL to form ⌬N-BCL-xL, which induces cell death, cytochrome c release, and large conductance channel activity in outer mitochondrial membranes (Bonanni et al. 2006; Clem et al. 1998; Fujita et al. 1998; Jonas et al. 2004 ). Indeed, ABT-737 inhibits both the large conductance channel activity of mitochondrial outer membranes and synaptic dysfunction induced by hypoxia, raising the possibility that ABT-737 binds to ⌬N-BCL-xL or prevents specific proteolytic cleavage of BCL-xL. Therefore the synaptic dysfunction of hypoxic synaptic terminals could be a result of the activity of proteolytically altered BCL-xL that has formed a new kind of channel in outer mitochondrial membranes (Bonanni et al. 2006; Jonas et al. 2004) . ABT-737, by inhibiting large conductance activity of mitochondrial membranes during hypoxia, could possibly prevent the release of factors from mitochondria that could in turn cause synaptic failure.
A traditional view of anti-apoptotic molecules such as BCL-xL is that they regulate and prevent cell death after a death stimulus (Antonsson et al. 1997; Cheng et al. 2001; Kluck et al. 1997; Oltersdorf et al. 2005; Plas and Thompson 2002; Plas et al. 2001; Vander Heiden et al. 2001) . Therefore inhibition of BCL-xL might produce injurious effects on synaptic function. Inhibition of full-length BCL-xL in the setting of hypoxia could, in and of itself, be expected to enhance the synaptic decline produced by hypoxia. These data do not support this notion, but are rather in keeping with the interpretation that the proteolytic cleavage product of BCL-xL, ⌬N BCL-xL, is the predominant form of BCL-xL present after the hypoxic stimulus. Indeed, in the presence of ABT-737 during either hypoxia or exposure to recombinant ⌬N BCL-xL, synaptic responses actually improved transiently, suggesting that the intermediate mitochondrial conductances resulting from the combination of the activity of the pro-apoptotic molecule and ABT were beneficial to the synapse, perhaps by transiently releasing ATP or other metabolites from mitochondria.
Our observations underscore the importance of BCL-xL as a modulator of both physiological and pathological functions of neurons. The effects of ABT-737 suggest that both BCL-xL and ⌬N-BCL-xL could help balance synaptic transmission between under-and overactivity, to protect against disuse leading to synaptic degeneration or elimination and overexcitation leading to excitotoxic death. In addition, the outer mitochondrial membrane ion channel activity of BCL-xL seems to participate in changes of mitochondrial conductance that are correlated with short-term synaptic plasticity and recovery of neurotransmission after repetitive firing. The consequences of these positive actions of BCL-xL at the synapse are as yet unclear, but it is likely that they could involve calcium buffering and the regulated release of ATP from mitochondria. Since ABT-737 mimics a natural ligand (BAD) for BCL-xL, it is possible that control of synaptic function by BCL-xL is normally controlled by BCL-xL-binding ligands. A protein such as BCL-xL that is so integrally related to mitochondrial function inside the synapse could also serve as sensor of synaptic activity, to provide for physiologically important changes in the properties of the synapse necessary for the eventual long-term changes in synaptic efficacy that underlie memory and learning.
